Literature DB >> 29135799

PERIPAPILLARY PACHYCHOROID SYNDROME.

Nopasak Phasukkijwatana1,2, K Bailey Freund3,4, Rosa Dolz-Marco3,4, Mayss Al-Sheikh5,6, Pearse A Keane7, Catherine A Egan7, Sandeep Randhawa8,9, Jay M Stewart10, Qingyun Liu10,11, Alex P Hunyor12,13, Allan Kreiger1, Aaron Nagiel1, Robert Lalane1, Mansour Rahimi1, Won Ki Lee14, Lee M Jampol15, David Sarraf1,16.   

Abstract

PURPOSE: To describe the features of peripapillary pachychoroid syndrome (PPS), a novel pachychoroid disease spectrum (PDS) entity.
METHODS: Medical records of 31 eyes (16 patients) with choroidal thickening associated with intraretinal and/or subretinal fluid in the nasal macula extending from the disk were reviewed (patients with PPS). Choroidal thickness was compared with 2 age-matched cohorts: typical PDS (17 eyes with central serous chorioretinopathy or pachychoroid neovasculopathy) and 19 normal eyes.
RESULTS: The patients with PPS were 81% men aged 71 ± 7 years. Peripapillary pachychoroid syndrome eyes displayed thicker nasal versus temporal macular choroids, unlike PDS eyes with thicker temporal macular choroids (P < 0.0001). Peripapillary intraretinal and/or subretinal fluid was often overlying dilated Haller layer vessels (pachyvessels). Fundus autofluorescence and fluorescein angiography illustrated peripapillary pigmentary mottling without focal leakage. Most PPS eyes (70%) exhibited other PDS findings including serous pigment epithelial detachment or gravitational tracks. Indocyanine green angiography illustrated dilated peripapillary pachyvessels and choroidal hyperpermeability. The disk was usually crowded, with edema noted in 4/31 (13%) eyes and mild late fluorescein disk leakage identified in half of the cases. Choroidal folds (77%), short axial lengths (39% less than 23 mm), and hyperopia (86%) were common.
CONCLUSION: Peripapillary pachychoroid syndrome is a distinct PDS variant, in which peripapillary choroidal thickening is associated with nasal macular intraretinal and/or subretinal fluid and occasional disk edema. Recognition of PPS is important to distinguish it from disorders with overlapping features such as posterior uveitis and neuro-ophthalmologic conditions.

Entities:  

Mesh:

Year:  2018        PMID: 29135799     DOI: 10.1097/IAE.0000000000001907

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  26 in total

1.  Foveal and parafoveal choroidal thickness pattern measuring by swept source optical coherence tomography.

Authors:  Pear Pongsachareonnont; Thanapong Somkijrungroj; Buravej Assavapongpaiboon; Theerada Chitamara; Maytavee Chuntarapas; Disorn Suwajanakorn
Journal:  Eye (Lond)       Date:  2019-04-08       Impact factor: 3.775

Review 2.  Pachychoroid disease spectrum: review article.

Authors:  Thiago José Muniz Machado Mazzeo; Henrique Monteiro Leber; Allan Gomes da Silva; Raimunda Cristina Mendonça Freire; Gabriel Castilho Sandoval Barbosa; Guilherme Garcia Criado; Gabriel Almeida Veiga Jacob; Cleide Guimarães Machado; André Marcelo Vieira Gomes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-14       Impact factor: 3.117

3.  Photodynamic therapy for peripapillary pachychoroid syndrome-a case report.

Authors:  George J Manayath; Shishir Verghese; Ratnesh Ranjan; Venkatapathy Narendran
Journal:  Digit J Ophthalmol       Date:  2021-01-27

Review 4.  A new insight into pachychoroid diseases: Remodeling of choroidal vasculature.

Authors:  Shoji Kishi; Hidetaka Matsumoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-16       Impact factor: 3.535

5.  Simultaneous multiple pachychoroid spectrum entities coexisting in the same eye.

Authors:  George J Manayath; Shishir Verghese; Ratnesh Ranjan; Venkatapathy Narendran
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

6.  Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study.

Authors:  Claudio Iovino; Enrico Peiretti; Filippo Tatti; Giuseppe Querques; Enrico Borrelli; Riccardo Sacconi; Jay Chhablani; Hitesh Agrawal; Camiel J F Boon; Elon H C van Dijk; Gilda Cennamo; Marco Lupidi; Alessio Muzi; Valentina Di Iorio; Matias Iglicki; Lital Smadar; Anat Loewenstein; Dinah Zur
Journal:  Eye (Lond)       Date:  2021-04-06       Impact factor: 3.775

7.  Non-Neovascular Pachychoroid Disease Mimicking Exudative Age-Related Macular Degeneration.

Authors:  Thachpacha Kaseewat; Nopasak Phasukkijwatana
Journal:  J Curr Ophthalmol       Date:  2021-03-26

8.  Prevalence of focal lamina cribrosa defects in eyes with pachychoroid disease spectrum.

Authors:  Hae Min Kang; Na Eun Lee; Jeong Hoon Choi; Hyoung Jun Koh; Sung Chul Lee
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

9.  One-Year Outcome of Combination Therapy with Full or Reduced Photodynamic Therapy and One Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy.

Authors:  Miki Sato-Akushichi; Shinji Ono; Tatsuro Taneda; Gerd Klose; Asuka Sasamori; Youngseok Song
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-15

Review 10.  Pachychoroid: current concepts on clinical features and pathogenesis.

Authors:  Veronica Castro-Navarro; Francine Behar-Cohen; Woohyok Chang; Antonia M Joussen; Timothy Y Y Lai; Rafael Navarro; Ian Pearce; Yasuo Yanagi; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-15       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.